Dr. Gurkishan Singh Chadha received his Ph.D. in Pharmaceutical Sciences with an emphasis in Pharmacokinetics, from The University at Buffalo (SUNY, Buffalo), New York. He has a strong educational background and diverse research experiences in pharmacology; pharmacokinetics and pharmaceutical sciences. He has researched, as well as published, regarding protein therapeutics in normal and type 2 diabetes mellitus. He has assessed the changes in the pharmacokinetic properties of proteins in diseased states such as type 2 diabetes mellitus, and diabetic nephropathy. His research domain involves using pharmacokinetic software’s (Phoenix, ADAPT, NONMEM) for creating models to analyzes the data obtained through PK studies. The projects during his research involved chronic disease studies in animals, q PCR analysis, microdialysis and in-vitro cell culture work. His recent work led to 2 research publications, and a review publication in peer-reviewed journals. Currently, as an Assistant Clinical Professor, in the department of pharmaceutical sciences at University of New England, Maine, he is looking to expand on his previous work, and will evaluate the mechanistic changes occurring due to diabetes mellitus and nephropathy, with the progression of disease. Furthermore, he has successfully submitted a teaching grant titled “Assessing Curricular Reinforcement of Pharmacy Compounding Skills” and it will evaluate the impact of repeated and instructor-independent compounding exercise for skill reinforcement, where instructors would assess the student’s quality of work, grades, ability to overcome errors and confidence between singly executed lab exercises versus reinforced lab exercises. While not in the laboratory, he spends his free time with his family, and loves outdoor activities, as well as taking hikes in the beautiful parks of Maine.

Pharmacokinetics; Pharmacology; PK/PD modelling; Protein Therapeutics and Diabetes.